4//SEC Filing
FINCK BARBARA K 4
Accession 0000899243-18-022461
CIK 0001512762other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:05 PM ET
Size
9.3 KB
Accession
0000899243-18-022461
Insider Transaction Report
Form 4
FINCK BARBARA K
Chief Medical Officer
Transactions
- Sale
Common Stock, $0.0001 par value
2018-08-13$19.02/sh−1,760$33,480→ 37,043 total - Exercise/Conversion
Stock Option (right to buy)
2018-08-13−1,760→ 84,701 totalExercise: $1.42Exp: 2023-11-21→ Common Stock (1,760 underlying) - Exercise/Conversion
Common Stock, $0.0001 par value
2018-08-13$1.42/sh+1,760$2,499→ 38,803 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $18.80 to $19.25, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]The shares underlying this option are fully vested and exercisable as of the date hereof.
Documents
Issuer
Coherus BioSciences, Inc.
CIK 0001512762
Entity typeother
Related Parties
1- filerCIK 0001242116
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:05 PM ET
- Size
- 9.3 KB